<bill session="117" type="hr" number="1017" updated="2023-03-09T17:47:48Z">
  <state datetime="2022-03-31T14:20:22-04:00">PASSED:SIMPLERES</state>
  <status>
    <unknown datetime="2022-03-31T14:20:22-04:00"/>
  </status>
  <introduced datetime="2022-03-31"/>
  <titles>
    <title type="display">Providing for consideration of the bill (H.R. 3617) to decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes; providing for consideration of the bill (H.R. 6833) to amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes; and for other purposes.</title>
    <title type="official" as="introduced">Providing for consideration of the bill (H.R. 3617) to decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes; providing for consideration of the bill (H.R. 6833) to amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes; and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="P000593"/>
  <cosponsors/>
  <actions>
    <action datetime="2022-03-31">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-03-31">
      <text>The House Committee on Rules reported an original measure, H. Rept. 117-285, by Mr. Perlmutter.</text>
    </action>
    <action datetime="2022-03-31T10:09:18-04:00">
      <text>The resolutions provides for one hour of general debate on H.R. 3617, under a structured rule. The resolution provides for one hour of general debate on H.R. 6833, under a closed rule. The rule provides that House Resolution 188, agreed to March 8, 2021, is amended by striking April 1, 2022 each place it appears and inserting April 29, 2022.</text>
    </action>
    <calendar datetime="2022-03-31" calendar="House" number="71">
      <text>Placed on the House Calendar, Calendar No. 71.</text>
    </calendar>
    <action datetime="2022-03-31T12:19:31-04:00">
      <text>Considered as privileged matter.</text>
      <reference ref="CR H4023-4033" label="consideration"/>
    </action>
    <action datetime="2022-03-31T12:23:42-04:00">
      <text>DEBATE - The House proceeded with one hour of debate on H. Res. 1017.</text>
    </action>
    <action datetime="2022-03-31T14:09:58-04:00">
      <text>On ordering the previous question Agreed to by the Yeas and Nays: 219 - 202 (Roll no. 98).</text>
    </action>
    <vote how="roll" type="vote" roll="99" datetime="2022-03-31T14:20:22-04:00" where="h" result="pass" state="PASSED:SIMPLERES">
      <text>On agreeing to the resolution Agreed to by the Yeas and Nays: 219 - 202 (Roll no. 99).</text>
      <reference ref="CR H4023" label="text"/>
    </vote>
    <action datetime="2022-03-31T14:20:24-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSRU" name="House Rules" subcommittee="" activity="Origin, Reporting"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="3617" relation="unknown"/>
    <bill session="117" type="h" number="6833" relation="procedurally-related"/>
  </relatedbills>
  <subjects>
    <term name="Congress"/>
    <term name="House of Representatives"/>
    <term name="Legislative rules and procedure"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-21T18:26:47Z" status="Passed House">This resolution provides for the consideration of H.R. 3617 (to decriminalize and deschedule cannabis) and H.R. 6833 (to establish cost sharing requirements for insulin products). The resolution also amends H.Res. 188 (regarding certain procedural requirements in the House of Representatives).</summary>
  <committee-reports>
    <report>H. Rept. 117-285</report>
  </committee-reports>
</bill>
